Supplement
Alpha-linolenic acid (ALA) is a plant-based omega-3 fat found in foods like flaxseed and walnuts, which the body uses for energy and can convert in small amounts into other omega-3s. People mostly look at it for blood pressure in those with obesity, and studies there found mixed results, though the evidence is moderate. Beyond that, research found no clear difference for blood sugar in type 2 diabetes, HDL cholesterol, or death from any cause, and that evidence is very limited.
Sources: PMID 9028717
- Updated
- How we grade
- 6 studies cited
- Best evidence
- Grade B
- Conditions studied
- 10
- Outcomes
- 62
- Graded outcomes
- 0208
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
Type 2 Diabetes
- Blood glucose
- Glucagon
- Triglycerides: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect on blood glucose | NoneNo effect | 1 study | 18,282 people | |||
Studies that measured blood glucose | ||||||
| Glucagon No effect on glucagon | NoneNo effect | 28 people | ||||
| Triglycerides | Changes; see studies | 3 studies | 39 people | |||
Studies that measured triglycerides
| ||||||
| HbA1c | Changes; see studies | 2 studies | 178 people | |||
Studies that measured hba1c | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 39 people | ||||
| Insulin | Changes; see studies | 469 people | ||||
| Insulin Resistance | Changes; see studies | 469 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 39 people | ||||
| Total cholesterol | Changes; see studies | 39 people | ||||
| Type 2 Diabetes Incidence | Changes; see studies | 18,243 people | ||||
Metabolic Health
- Blood glucose
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect on blood glucose | NoneNo effect | 1 study | 18,243 people | |||
Studies that measured blood glucose | ||||||
General Cardiovascular Health
- All-Cause Mortality
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| All-Cause Mortality No effect on all-cause mortality | NoneNo effect | 19,327 people |
Cardiovascular Disease
- All-Cause Mortality
- Triglycerides: changes; see studies
- Body Mass Index (BMI): changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| All-Cause Mortality No effect on all-cause mortality | NoneNo effect | 19,327 people | ||||
| Triglycerides | Changes; see studies | 3 studies | 1,776 people | |||
Studies that measured triglycerides
| ||||||
| Body Mass Index (BMI) | Changes; see studies | 1,581 people | ||||
| Cardiovascular Disease Mortality | Changes; see studies | 18,619 people | ||||
| Coronary Artery Disease Risk | Changes; see studies | 19,061 people | ||||
| Heart Arrhythmias | Changes; see studies | 4,912 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1,776 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 2,201 people | ||||
| Major Adverse Cardiac Events | Changes; see studies | 110 people | ||||
| Total cholesterol | Changes; see studies | 2,164 people | ||||
Dyslipidemia
- High-density lipoprotein (HDL)
- Triglycerides: changes; see studies
- Low-density lipoprotein (LDL): changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) No effect on HDL cholesterol | NoneNo effect | 2,640 people | ||||
| Triglycerides | Changes; see studies | 3 studies | 2,630 people | |||
Studies that measured triglycerides
| ||||||
| Low-density lipoprotein (LDL) | Changes; see studies | 2,640 people | ||||
| Total cholesterol | Changes; see studies | 2,630 people | ||||
| Total-/HDL-cholesterol ratio | Changes; see studies | 726 people | ||||
| vLDL-C | Changes; see studies | 337 people | ||||
Polycystic Ovary Syndrome (PCOS)
- Adiponectin
- Triglycerides: changes; see studies
- HbA1c: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect on adiponectin | NoneNo effect | 51 people | ||||
| Triglycerides | Changes; see studies | 3 studies | 51 people | |||
Studies that measured triglycerides
| ||||||
| HbA1c | Changes; see studies | 2 studies | 51 people | |||
Studies that measured hba1c | ||||||
| Blood glucose | Changes; see studies | 1 study | 51 people | |||
Studies that measured blood glucose | ||||||
| Apolipoprotein B | Changes; see studies | 51 people | ||||
| C-Reactive Protein (CRP) | Changes; see studies | 51 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 51 people | ||||
| Insulin | Changes; see studies | 51 people | ||||
| Insulin Resistance | Changes; see studies | 51 people | ||||
| Leptin | Improves (the measure goes up) | 51 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 51 people | ||||
| Total cholesterol | Changes; see studies | 51 people | ||||
Immune Health
- B Cell Count
- Oxidative Stress Biomarkers: changes; see studies
- Natural Killer Cell Activity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect on B cell count | NoneNo effect | 46 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 1 study | 46 people | |||
Studies that measured oxidative stress biomarkers | ||||||
| Natural Killer Cell Activity | Improves (the measure goes up) | 46 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 46 people | ||||
| T Cell Count | Improves (the measure goes up) | 46 people | ||||
Migraine Headache
- Migraine Frequency: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Migraine Frequency | Changes; see studies | 1 study | 80 people | |||
Key findings
- Blood Pressure
- Blood glucose
- Glucagon
Shop the evidence-backed picks
Third-party tested Alpha-Linolenic Acid (ALA) products, in the forms the graded studies used where we can match them.
- Grade B
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
6 studies from PubMed
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- Effects of α-linolenic acid intake on blood lipid profiles:a systematic review and meta-analysis of randomized controlled trials
- Effect of dietary alpha-linolenic acid on blood inflammatory markers: a systematic review and meta-analysis of randomized controlled trials.
- Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials.
- Effect of Alpha-Linolenic Acid Supplementation on Cardiovascular Disease Risk Profile in Individuals with Obesity or Overweight: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The effects of concurrent alpha-linolenic acid, L-carnitine supplementation on clinical symptoms, mental health, and quality of life in women with migraine: a randomized, triple-blind, placebo-controlled trial.